Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected kenyan children with treatment failureLWEMBE, Raphael; OCHIENG, Washingtone; OWENS, Mary et al.Journal of medical virology. 2007, Vol 79, Num 7, pp 865-872, issn 0146-6615, 8 p.Article

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled studyGEISSE, John K; RICH, Phoebe; PANDYA, Amit et al.Journal of the American Academy of Dermatology. 2002, Vol 47, Num 3, pp 390-398, issn 0190-9622, 9 p.Article

Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeksQUIRK, Chris; GEBAUER, Kurt; OWENS, Mary et al.Australasian journal of dermatology. 2006, Vol 47, Num 4, pp 258-265, issn 0004-8380, 8 p.Article

Safety studies of topical imiquimod 5% cream on normal skin exposed to ultraviolet radiationKAIDBEY, Kays; OWENS, Mary; LIBERDA, Margo et al.Toxicology (Amsterdam). 2002, Vol 178, Num 2, pp 175-182, issn 0300-483XArticle

Changes in the HIV Type 1 Envelope Gene from Non-Subtype B HIV Type 1-Infected Children in KenyaLWEMBE, Raphael; LIHANA, Raphael W; OWENS, Mary et al.AIDS research and human retroviruses. 2009, Vol 25, Num 2, pp 141-147, issn 0889-2229, 7 p.Article

Characterizing Anxious Children with an Obsessive Difficult TemperamentWOOD, Hayley; MANASSIS, Katharina; OWENS, Mary et al.Clinical child psychology and psychiatry. 2009, Vol 14, Num 1, pp 85-99, issn 1359-1045, 15 p.Article

Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream : interim 2-year results from an ongoing 5-year follow-up study in europeGOLLNICK, Harald; BARONA, Carlos Guillén; FRANK, Ronald G. J et al.EJD. European journal of dermatology. 2005, Vol 15, Num 5, pp 374-381, issn 1167-1122, 8 p.Article

5% Imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinomaTORRES, Abel; NIEMEYER, Agnieszka; BERKES, Beatrice et al.Dermatologic surgery. 2004, Vol 30, Num 12, pp 1462-1469, issn 1076-0512, 8 p., 1Article

Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapyLIHANA, Raphael W; LWEMBE, Raphael M; SONGOK, Elijah M et al.Journal of clinical virology. 2011, Vol 52, Num 2, pp 123-128, issn 1386-6532, 6 p.Article

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studiesGEISSE, John; CARO, Ivor; LINDHOLM, Jane et al.Journal of the American Academy of Dermatology. 2004, Vol 50, Num 5, pp 722-733, issn 0190-9622, 12 p.Article

Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimensSHUMACK, Stephen; ROBINSON, June; KOSSARD, Steven et al.Archives of dermatology (1960). 2002, Vol 138, Num 9, pp 1165-1171, issn 0003-987X, 7 p.Article

Group and individual cognitive-behavioral therapy for childhood anxiety disorders: A randomized trialMANASSIS, Katharina; MENDLOWITZ, Sandra L; SCAPILLATO, Donna et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2002, Vol 41, Num 12, pp 1423-1430, issn 0890-8567, 8 p.Article

Imiquimod 5% cream in the treatment of Bowen's diseaseMACKENZIE-WOOD, Andrew; KOSSARD, Steven; DE LAUNEY, John et al.Journal of the American Academy of Dermatology. 2001, Vol 44, Num 3, pp 462-470, issn 0190-9622Article

Topical Imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populationsSAUDER, Daniel N; SKINNER, Robert B; FOX, Terry L et al.Sexually transmitted diseases. 2003, Vol 30, Num 2, pp 124-128, issn 0148-5717, 5 p.Article

Self-efficacy and distress in women with AIDS: the SMART/EST women's projectJONES, Deborah L; OWENS, Mary Ishii; LYDSTON, David et al.AIDS Care (Print). 2010, Vol 22, Num 12, pp 1499-1508, issn 0954-0121, 10 p.Article

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma : Results of a multicenter 6-week dose-response trialMARKS, Robin; GEBAUER, Kurt; SHUMACK, Stephen et al.Journal of the American Academy of Dermatology. 2001, Vol 44, Num 5, pp 807-813, issn 0190-9622Article

Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a dayFIFE, Kenneth H; FERENCZY, Alex; DOUGLAS, John M et al.Sexually transmitted diseases. 2001, Vol 28, Num 4, pp 226-231, issn 0148-5717Article

Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and armsHARRISON, Lester I; SKINNER, Shari L; MARBURY, Thomas C et al.Archives of dermatological research (Print). 2004, Vol 296, Num 1, pp 6-11, issn 0340-3696, 6 p.Article

Mortality Associated with Implantation and Management of Intrathecal Opioid Drug Infusion Systems to Threat Noncancer PainCOFFEY, Robert J; OWENS, Mary L; BROSTE, Steven K et al.Anesthesiology (Philadelphia). 2009, Vol 111, Num 4, pp 881-891, issn 0003-3022, 11 p.Article